Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Parkinson's Disease

Free Subscription 12.10.2026 2 Biochemistry (Mosc) 1 BMC Neurosci 1 Exp Neurol 3 J Neural Transm (Vienna) 2 JAMA 3 Mov Disord 1 Nature 1 Neurobiol Dis 3 Neurology 1 Neuroscience 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Biochemistry (Mosc)

1. LAVRINOVA AO, Litusova EM, Dmitriev AA, Melnikova NV, et al
   DNA Methylation of the SNCA Intron 1 and Alpha-Synuclein Expression in the CD45+ Blood Cells in Parkinson's Disease.
   Biochemistry (Mosc). 2026;91:1629-1643.
   PubMed         Abstract available
   
   
2. USENKO TS, Bezrukova AI, Basharova KS, Grigor'eva EV, et al
   mTOR and STING Modulation Restores Hydrolase Activities and Decreases Alpha-Synuclein Pathology in the Cells from the Patients with GBA1-Associated Parkinson's Disease.
   Biochemistry (Mosc). 2026;91:1596-1614.
   PubMed         Abstract available
   
   

   
   BMC Neurosci

3. YANG ST, Chen YC, Kao TJ, Kuo CW, et al
   Oral sodium butyrate alleviates motor deficits and dopaminergic neuronal loss in 6-hydroxydopamine-induced Parkinson's disease rat model.
   BMC Neurosci. 2026;27:43.
   PubMed         Abstract available
   
   

   
   Exp Neurol

4. YIN H, Zhao D, Wang Y
   Norepinephrine modulates the microglial response and protects against MPTP-induced Parkinson's disease pathology through regulation of the PI3K/AKT/mTOR pathway.
   Exp Neurol. 2026 Oct 7:116048. doi: 10.1016/j.expneurol.2026.116048.
   PubMed         Abstract available
   
   

   
   J Neural Transm (Vienna)

5. WESTENBERGER A, Endaya NJ, Bruggemann N
   Does genetic testing remain relevant in advanced Parkinson's disease?
   J Neural Transm (Vienna). 2026 Oct 6. doi: 10.1007/s00702-026-03295.
   PubMed         Abstract available
   
   
6. LIMPIADO CJE, Saranza G
   Social media utilization to understand the journey and unmet needs of patients with Parkinson's disease in the Philippines.
   J Neural Transm (Vienna). 2026 Oct 3. doi: 10.1007/s00702-026-03268.
   PubMed         Abstract available
   
   
7. DE CAROLIS L, Bianchini E, Alborghetti M, Pacilio P, et al
   The safety and tolerability of opicapone in elderly Parkinson's disease patients: a real-world, multicenter, retrospective study.
   J Neural Transm (Vienna). 2026 Oct 3. doi: 10.1007/s00702-026-03284.
   PubMed         Abstract available
   
   

   
   JAMA

8. 
   Nicotinamide Riboside for Patients With Early-Stage Parkinson Disease: Research Summary.
   JAMA. 2026 Oct 8:e2618859. doi: 10.1001/jama.2026.18859.
   PubMed        
   
   
9. BRAKEDAL B, Skeie GO, Derad C, Alstadhaug KB, et al
   Nicotinamide Riboside for Patients With Early-Stage Parkinson Disease: The NOPARK Randomized Clinical Trial.
   JAMA. 2026 Oct 8. doi: 10.1001/jama.2026.18828.
   PubMed         Abstract available
   
   

   
   Mov Disord

10. SCHOEN I, Wang J, Xie SX, Caspell-Garcia C, et al
    Neuropsychiatric and Cognitive Symptom Evolution over the First Decade of Biomarker-Positive, Sporadic Parkinson's Disease.
    Mov Disord. 2026 Oct 6. doi: 10.1002/mds.70557.
    PubMed         Abstract available
    
    
11. CORVOL JC, Tesson C, Liot S, Carvalho S, et al
    Building Scalable Recruitment Models for Precision Medicine in Parkinson's Disease: Insights from GBA1 Trials.
    Mov Disord. 2026 Oct 8. doi: 10.1002/mds.70537.
    PubMed        
    
    
12. SCHEPERJANS F, Borghammer P, Pfeiffer RF, Appel-Cresswell S, et al
    The Gut-Brain Axis in Parkinson's Disease: From Clinical Observation toward Mechanism-Based Precision Medicine.
    Mov Disord. 2026 Oct 8. doi: 10.1002/mds.70566.
    PubMed         Abstract available
    
    

    
    Nature

13. HOLLEY G, Eggertsson HP, Kristmundsdottir S, Beyter D, et al
    An Icelandic pangenome reference.
    Nature. 2026;658:421-429.
    PubMed         Abstract available
    
    

    
    Neurobiol Dis

14. QIAN S, Xiang W, Chen K, Du Y, et al
    Plasma PINK1/Parkin ratio and ATF5 as potential biomarkers associated with dyskinesia in Parkinson's disease.
    Neurobiol Dis. 2026;230:107638.
    PubMed         Abstract available
    
    

    
    Neurology

15. DI BIASE L, Pecoraro PM, Bugamelli F, Di Carluccio M, et al
    Relationship Between Braak and Clinical Stage in Autopsy-Confirmed Parkinson Disease: A UK Brain Bank Study.
    Neurology. 2026;107:e218469.
    PubMed         Abstract available
    
    
16. RODRIGUEZ-VIOLANTE M
    The Braak Paradox: When Parkinson Pathology and Clinical Progression Disconnect.
    Neurology. 2026;107:e218535.
    PubMed        
    
    
17. RYU DW, Duque KR, Marsili L, Abanto J, et al
    Physical Activity and Motor and Cognitive Progression in Parkinson Disease: A Longitudinal Cohort Study.
    Neurology. 2026;107:e218682.
    PubMed         Abstract available
    
    

    
    Neuroscience

18. HEYDARPOUR H, Ashtiani MN, Bahrpeyma F, Tafakhori A, et al
    Frontal aperiodic activity and sensorimotor theta clustering are differentially modulated by tDCS during proprioceptive training in Parkinson's disease: An EEG study.
    Neuroscience. 2026;617:154-161.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

19. WU Y, Xu P, Moran J, Xu CS, et al
    Dystrophic changes of nigrostriatal axons harboring a SYNJ1 Parkinson's mutation suggest catastrophic failure of endocytic mechanisms.
    Proc Natl Acad Sci U S A. 2026;123:e2622215123.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum